Shopping Cart
Remove All
Your shopping cart is currently empty
Povetacicept
🥰Excellent
Catalog No. T9901A-1512Cas No. 2490217-42-8
Alias ALPN-303
Povetacicept (ALPN-303) is an engineered fusion protein that incorporates the TACI domain and functions as a dual antagonist of APRIL/BAFF. It modulates B lymphocytes and pathogenic autoantibodies and is being researched for its potential application in treating lupus and other autoimmune diseases associated with B cells.
Povetacicept
Povetacicept
🥰Excellent
Catalog No. T9901A-1512Alias ALPN-303Cas No. 2490217-42-8
Povetacicept (ALPN-303) is an engineered fusion protein that incorporates the TACI domain and functions as a dual antagonist of APRIL/BAFF. It modulates B lymphocytes and pathogenic autoantibodies and is being researched for its potential application in treating lupus and other autoimmune diseases associated with B cells.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Povetacicept (ALPN-303) is an engineered fusion protein that incorporates the TACI domain and functions as a dual antagonist of APRIL/BAFF. It modulates B lymphocytes and pathogenic autoantibodies and is being researched for its potential application in treating lupus and other autoimmune diseases associated with B cells. |
| Synonyms | ALPN-303 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | ＜ 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | APRIL/BAFF |
| Cas No. | 2490217-42-8 |
Storage & Solubility Information
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Povetacicept | purchase Povetacicept | Povetacicept cost | order Povetacicept
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.